These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 18594960)

  • 1. Beware of over-interpreting negative trials.
    Scahill L; Aman MG; McCracken JT; McDougle CJ; Vitiello B
    J Autism Dev Disord; 2008 Oct; 38(9):1609-10. PubMed ID: 18594960
    [No Abstract]   [Full Text] [Related]  

  • 2. Liquid risperidone in the treatment of psychotic agitation.
    Tsai C; Puzantian T
    CNS Drugs; 2002; 16(11):777; author reply 778. PubMed ID: 12383033
    [No Abstract]   [Full Text] [Related]  

  • 3. Brief report: risperidone for severely disturbed behavior and tardive dyskinesia in developmentally disabled adults.
    Khan BU
    J Autism Dev Disord; 1997 Aug; 27(4):479-89. PubMed ID: 9261670
    [No Abstract]   [Full Text] [Related]  

  • 4. Risperidone in the management of agitation in HIV dementia.
    Lodge P; Tanner M; McKeogh MM
    Palliat Med; 1998 May; 12(3):206-7. PubMed ID: 9743841
    [No Abstract]   [Full Text] [Related]  

  • 5. Risperidone for Psychosis-Induced Aggression or Agitation.
    Scruth E
    Issues Ment Health Nurs; 2019 Nov; 40(11):988-989. PubMed ID: 31381459
    [No Abstract]   [Full Text] [Related]  

  • 6. Licensed indication for risperidone in dementia.
    Phizackerley D
    BMJ; 2014 Dec; 349():g7337. PubMed ID: 25498536
    [No Abstract]   [Full Text] [Related]  

  • 7. Duration of risperidone treatment for BPSD.
    Snowdon J; Brodaty H; Ames D; Day S
    Int J Geriatr Psychiatry; 2006 Jul; 21(7):699-701. PubMed ID: 16821255
    [No Abstract]   [Full Text] [Related]  

  • 8. Risperidone in the management of agitation and aggression associated with psychiatric disorders.
    De Deyn PP; Buitelaar J
    Eur Psychiatry; 2006 Jan; 21(1):21-8. PubMed ID: 16414250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discontinuation of risperidone in Alzheimer's disease.
    Ling SM; Bonner AF; McMullen TL
    N Engl J Med; 2013 Jan; 368(2):187. PubMed ID: 23301740
    [No Abstract]   [Full Text] [Related]  

  • 10. Discontinuation of risperidone in Alzheimer's disease.
    Power GA
    N Engl J Med; 2013 Jan; 368(2):186-7. PubMed ID: 23301739
    [No Abstract]   [Full Text] [Related]  

  • 11. Discontinuation of risperidone in Alzheimer's disease.
    Gnjidic D; Hilmer SN
    N Engl J Med; 2013 Jan; 368(2):186. PubMed ID: 23301738
    [No Abstract]   [Full Text] [Related]  

  • 12. Discontinuation of risperidone in Alzheimer's disease.
    Devanand DP; Schultz SK; Sultzer DL
    N Engl J Med; 2013 Jan; 368(2):187-8. PubMed ID: 23301737
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of risperidone on nursing burden associated with caring for patients with dementia.
    Asghar Ali AA; Espinoza R; Kavirajan H; Read S
    J Am Geriatr Soc; 2005 Jul; 53(7):1261-2; author reply 1262-3. PubMed ID: 16108953
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of risperidone for psychosis and agitation in demented patients with Parkinson's disease.
    Workman RH; Orengo CA; Bakey AA; Molinari VA; Kunik ME
    J Neuropsychiatry Clin Neurosci; 1997; 9(4):594-7. PubMed ID: 9447503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Longterm treatment with Risperidone in Alzheimer's disease? No justification for more "drug deaths" in nursing homes!].
    Förstl H
    Dtsch Med Wochenschr; 2013 Jan; 138(1-2):16. PubMed ID: 23250689
    [No Abstract]   [Full Text] [Related]  

  • 16. An unsubstantiated conclusion.
    Reifler BV; Blazer D
    Am J Geriatr Psychiatry; 2015 Feb; 23(2):220. PubMed ID: 25575935
    [No Abstract]   [Full Text] [Related]  

  • 17. Atypical antipsychotic agents ineffective for AD.
    Duke Med Health News; 2007 Jan; 13(1):8. PubMed ID: 17299888
    [No Abstract]   [Full Text] [Related]  

  • 18. Galantamine versus risperidone treatment of neuropsychiatric symptoms in patients with probable dementia: an open randomized trial.
    Bogaisky M
    Am J Geriatr Psychiatry; 2014 Sep; 22(9):951. PubMed ID: 25109421
    [No Abstract]   [Full Text] [Related]  

  • 19. Don't use antipsychotics routinely to treat agitation and aggression in people with dementia.
    Corbett A; Burns A; Ballard C
    BMJ; 2014 Nov; 349():g6420. PubMed ID: 25368388
    [No Abstract]   [Full Text] [Related]  

  • 20. Response to Bogaiksy's letter to the editor.
    Freund-Levi Y; Jedenius E; Wahlund LO; Eriksdotter M; Tysen-Bäckström AC; Lärksäter M
    Am J Geriatr Psychiatry; 2014 Sep; 22(9):951. PubMed ID: 25109420
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.